A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin (A Drug Interaction Study With a CYP3A4/5 Inhibitor or Inducer)
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Sipagladenant (Primary) ; Clarithromycin; Rifampicin
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Kyowa Kirin
- 27 Nov 2019 Status changed from recruiting to completed.
- 03 Sep 2019 New trial record
- 29 Aug 2019 Status changed from not yet recruiting to recruiting.